Will the State be able to fund stem cell research in future?
Stem cells can be defined as undifferentiated cells that are capable of turning into particular types of cells in the body. Up to now, it is apparent that it is one of the best remedies for several complications that include, heart attack, spinal cord injury, diabetes, stroke, Alzheimer’s and Parkinson’s illnesses.
Since its discovery, there has been a lot of debates of whether some types of stem cells could work or not. Among the most controversial forms is the stem cells that are obtained from the human embryo. There are a few groups who don’t agree with the way the embryonic stem cells are obtained simply because it involves the destruction of the human embryo.
In the year 2001, President Bush made it clear that he was going to allow stem cell research to be funded federally after confirmation of death. He further stated that no federal funds would be availed for new stem cell lines. There have been several issues on the matter. A review on the matter was aired two times on a 60-minute television show on 12th and 26th February in the year 2006.
In New Jersey, the Democrats fully accept stem cell funding while some Republicans oppose it. The New Jersey has suggested spending up to $150 million on research that has fewer controversies such as stem cells from placentas, cord blood, and other tissues. It also proposed to spend $50 to fund its clinical trials as well as commercial applications.
However, commercial application has been faced with a series of problems, for example, a legal opinion that proposed that the bonds exempted from the tax could not be used for funding research in which a state would have a share of the profits made by the research. In March 2006 a new issue emerged. Patent holders wanted the researchers to pay some fees for using their patents to do the research. Funnily, this debate resulted from a clash between two states, WARF of Wisconsin and CIRM of California.
In short, it is important to realize that the federal funding of stem cell research is meant to build up new medical horizons that may pay off holders of rights that are already in place. Recently, the Supreme Court came to an agreement that was more favorable to researchers who were in need of approval by a federal regulatory body such as FDA.
This exemption was intended to ease the effects of previous claims for example, what Wisconsin said about California. But this doesn’t mean that the expectations should be set too high. One question remains, will the state be in a position to fund an embryonic stem cell therapy that is FDA approved in the coming ten years? By what is going on, one might expect positive results. However, it is time to eliminate the possibilities of obstructions along the way.
Call us today if you need help with this topic and more on 8432131480.



